J., 1 (3), 26-45
What they found: Dose-dependent stimulation of type II collagen (up to 2.5 baseline at 100 nM) Stimulation of aggrecan (up to 1.8 baseline) Inhibition of MMP-13 by ~40 % Partial protection against IL-1-induced matrix degradation Why it matters: It opened a completely new research area for AOD-9604 beyond lipolysis
Munoz at Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD, USA
GHK-Cu 100mg is used to study its effects on collagen synthesis, wound healing, and antioxidant defense in controlled laboratory settings, focusing on its copper-peptide complex mechanism
Williams G, King J, Cunningham M, Stephan M, Kerr B, Hersh JH
Die Plasmakonzentration von GHK-Cu nimmt mit dem Alter signifikant ab: von etwa 200 ng/mL im Alter von 20 Jahren auf etwa 80 ng/mL um das 60